O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.36B
AUM Growth
-$2.91B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
161
New
Increased
Reduced
Closed

Top Buys

1 +$78.1M
2 +$77.1M
3 +$59.3M
4
CELG
Celgene Corp
CELG
+$58.5M
5
GH icon
Guardant Health
GH
+$56.5M

Top Sells

1 +$149M
2 +$98.5M
3 +$81.7M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81M
5
EW icon
Edwards Lifesciences
EW
+$79.7M

Sector Composition

1 Healthcare 96%
2 Financials 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$257M 4.79%
10,889,280
2
$256M 4.78%
4,087,373
-68,518
3
$251M 4.69%
835,249
-75,051
4
$209M 3.9%
3,256,700
+792,850
5
$205M 3.82%
5,790,400
-2,073,595
6
$199M 3.72%
2,047,400
-833,703
7
$191M 3.56%
2,614,760
-1,099,771
8
$188M 3.51%
1,133,200
-467,300
9
$134M 2.49%
4,905,899
-1,533,669
10
$128M 2.39%
957,000
-193,405
11
$123M 2.29%
10,425,225
12
$109M 2.04%
3,986,200
-793,400
13
$97.9M 1.83%
437,500
-230,500
14
$92.4M 1.72%
+5,316,355
15
$91.7M 1.71%
482,700
-151,200
16
$85.2M 1.59%
781,000
-73,400
17
$83M 1.55%
222,100
-172,300
18
$81.7M 1.52%
511,500
+234,900
19
$80.2M 1.5%
305,400
-168,600
20
$77.3M 1.44%
1,829,449
-614,772
21
$73.8M 1.38%
252,785
-22,205
22
$71.4M 1.33%
2,605,713
23
$71.3M 1.33%
1,396,800
-1,575,000
24
$70.9M 1.32%
4,967,403
+638,830
25
$67.3M 1.26%
+6,466,783